Search for: "Actavis"
Results 641 - 660
of 1,010
Sort by Relevance
|
Sort by Date
17 Oct 2013, 12:19 pm
This question related to whether the combination product is protected by the amended patent and stems from the idea advanced by Actavis and by Arnold J in Actavis v Sanofi that the combination product may need to embody a separate inventive advance. [read post]
17 Oct 2013, 11:09 am
Xerox relied on the same scope of the patent standard rejected in Actavis to immunize a patent holder’s unilateral refusal to license; that holding is open to question today. [read post]
17 Oct 2013, 5:00 am
Our panelists include the attorney who argued Actavis in the Supreme Court, the leading academician on the subject, trial counsel in Cipro and other class action challenges to reverse settlements, and is moderated by the attorney who filed the Actavis Case. [read post]
13 Oct 2013, 8:36 pm
October 15-17, 2013 - Business of Biosimilars*** (Institute for International Research) - Boston, MA October 16, 2013 - Post-Grant Review -- Coming Soon (Intellectual Property Owners Association) - 2:00 to 3:00 pm (ET) October 22, 2013 - Patent 'Trolls' Under Fire: Strategies, Tactics and Legislation Impacting University Patents & Licensing (Technology Transfer Tactics) - 1:00 to 2:00 pm (Eastern) October 22, 2013 - Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act… [read post]
11 Oct 2013, 9:34 pm
The American Bar Association (ABA) Section of Intellectual Property Law, Young Lawyers Division, and Center for Professional Development will be offering a live webinar on "Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act Post-Actavis" on October 22, 2013 from 2:00 to 3:30 pm (Eastern). [read post]
30 Sep 2013, 4:50 am
Mark Lemley's Firm Files DJ Against Myriad in Northern California ----- Promise Not to Infringe Insufficient in ANDA Litigation ----- Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 ----- Mylan Settles with FTC over Agila Acquisition from Strides ----- Amgen and ShanghaiTech University Announce China R&D Center ----- Forest Laboratories sues over SAVELLA® generics ----- Teva Pharmaceutical scores patent cictory over Mylan on AZILECT® ----- Patent Awarded to New… [read post]
22 Sep 2013, 6:58 am
Actavis The following articles are pre-publication versions of articles that will appear in MJLST Volume 15, Issue 1. [read post]
23 Aug 2013, 3:27 am
Actavis, the Court confronted the law governing a controversial pharmaceutical marketing practice known as reverse payment agreements, or pay for delay.1 This practice occurs when a generic drug company identifies a vulnerable patent held by a brand-name drug manufacturer and seeks approval from the Food and Drug Administration (FDA) for a generic version before the patent expires, provoking a lawsuit for infringement. [read post]
22 Aug 2013, 9:59 pm
Actavis), the Federal Trade Commission has filed an amicus curiae brief with the District Court of New Jersey in In re Effexot XR Antitrust Litigation. [read post]
22 Aug 2013, 1:34 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals, which is now known as Actavis, Inc. [read post]
20 Aug 2013, 7:57 am
Actavis South Atlantic LLC, et al., C.A. [read post]
16 Aug 2013, 12:39 pm
Hovenkamp, Anticompetitive Patent Settlements and the Supreme Court's Actavis Decision, 15 Minn. [read post]
16 Aug 2013, 9:57 am
Actavis to a patent settlement containing a “no-authorized-generic” commitment. [read post]
16 Aug 2013, 9:57 am
Actavis to a patent settlement containing a “no-authorized-generic” commitment. [read post]
29 Jul 2013, 8:45 am
Actavis the Supreme Court held that settlement of a patent infringement suit in which the patentee of a... [read post]
29 Jul 2013, 5:00 am
Actavis,... [read post]
14 Jul 2013, 9:01 pm
Actavis: Practical Implications of the Landmark Supreme Court Decision (Law Seminars International) - 3:00 to 4:00 pm (Eastern) July 17, 2013 - European biotech patent law update (D Young & Co) - 4:00 am, 7:00 am, 12:00 pm (EDT) July 17, 2013 - The Myriad Decision: Practical Implications for Biotechnology Companies Protecting IP Assets (Law Seminars International) - 3:00 to... [read post]
11 Jul 2013, 7:37 am
Actavis. [read post]
9 Jul 2013, 7:38 am
Here are just a few of the larger healthcare M&A deals in 2013: Valeant Pharmaceuticals to acquire Bausch + Lomb Holdings for $8.7 billion Actavis to acquire Warner Chilcott for approximately $8.5 billion McKesson acquires PSS World Medical for approximately $2.1 billion Catholic Health Initiatives acquires St. [read post]
5 Jul 2013, 8:42 pm
Actavis: Practical Implications of the Landmark Supreme Court Decision" on July 16, 2013 from 3:00 to 4:00 pm (Eastern). [read post]
